Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, is one of six international researchers awarded funding through the Alzheimer’s Association's Part the Cloud program to support early phase human trials of potential therapies to save brain cells.

Its ample sun puts residents at risk for melanoma, but Arizona is also home to experimental treatments through early-phase clinical trials at the University of Arizona Cancer Center.

Banner Health has launched new clinical practice protocols developed with input from the University of Arizona Valley Fever Center for Excellence to help physicians more quickly diagnose and treat patients with Valley fever infections.

Dr. Parent-Johnson will lead the UA Sonoran Center, which focuses on the issues of health, wellness, employment and community inclusion for adults with developmental and other disabilities, across the life span.

The University of Arizona Cancer Center is building a robust tobacco-cessation program to provide support to tobacco users hoping to quit.

Researchers at the University of Arizona Mel and Enid Zuckerman College of Public Health and the Department of Family and Community Medicine at the UA College of Medicine – Tucson received a $347,000 grant from the National Institutes of Health to study how the menstrual cycle impacts quit efforts in women of reproductive age who smoke.

As this public health crisis escalates, researchers are working fervently to better understand the disease and who is most at risk for developing it, as well as to find ways to detect it earlier and to slow or halt its progress.

Donata Vercelli, MD, has been elected secretary general of the Collegium Internationale Allergologicum, a group of distinguished international physicians and scientists who study the emerging field of allergy and clinical immunology. As secretary general, Dr. Vercelli eventually will become the first female president of the organization.

As physicians begin to order an increasing number of genetic tests, a question remains: who can help patients, and sometimes providers, interpret genetic information?

NIH grant will allow Taben Hale, PhD, to study cardiac fibroblasts.